Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 52, Issue 2, 1997, Pages

  Joosten, Etienne ^a   Lesaffre, Emmanuel ^a   Riezler, Reiner ^b   Ghekiere, Veronique ^a   Dereymaeker, Lutgart ^a   Pelemans, Walter ^a   Dejaeger, Eddy ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Severi Med   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID;

AGED; ALZHEIMER DISEASE; ANEMIA; ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; KIDNEY FAILURE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEGALOCYTOSIS; PREVALENCE; PRIORITY JOURNAL;

EID: 0031003514     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/52A.2.M76     Document Type: Article

References (29)

1. Skoog I, Nilsson L, Palmertz B, et al. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-8.
2. Ott A, Breteler MB, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Br Med J 1995;310:970-3.
3. Hector M, Burton JR. What are the psychiatric manifestations of vitamin B12 deficiency? J Am Geriatr Soc 1988;36:1105-12.
4. Cole MG, Prchal JF. Low serum vitamin B12 in Alzheimer-type dementia. Age Ageing 1984;13:101-5.
5. Karnaze DS, Carmel R. Low serum cobalamin levels in primary degenerative dementia. Do some patients harbor atypical cobalamin deficiency states? Arch Intern Med 1987;147:429-31.
6. Kristensen MO, Gulmann NC, Christensen JEJ, et al. Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand 1993;87:475-81.
7. Ikeda T, Furukawa Y, Mashimoto S, et al. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. Acta Psychiatr Scand 1990;82:327-9.
8. Bottiglieri T, Godfrey P, Flynn T, et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990;53:1096-8.
9. Basun H, Fratiglioni L, Winblad B. Cobalamin levels are not reduced in Alzheimer's disease: results from a population based study. J Am Geriatr Soc 1994;42:132-6.
10. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994;42:933-6.
11. Savage DG, Lindenbaum J, Stabler JP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46.
12. Green R. Metabolite assays in cobalamin and folate deficiency. Balliere's Clinical Haematology 1995;8:533-66.
13. Joosten E, van den Berg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-76.
14. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995;346:85-9.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev.: DSM-111-R. Washington, DC: American Psychiatric Association, 1987.
16. McKahnn G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
18. Hachinski VC, Illif LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
19. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
20. Stabler SP, Marcell PD, Podell ER, et al. Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest 1986;77:1606-12.
21. Stabler SP, Marcell PD, Podell ER, et al. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988;81:466-74.
22. Santhosh-Kumar CR, Hassell KL, Deutsch JC, Kolhouse JF. Are neuropsychiatric manifestations of folate, cobalamin and pyridoxine deficiency mediated through imbalances in excitatory sulfur amino acids? Med Hypotheses 1994;43:239-44.
23. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
24. Nordstrom M, Kjellstrøm T. Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocysteinemia and atherosclerotic vascular disease. Atherosclerosis 1992;94:213-21.
25. Nygård O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. JAMA 1995;274:1526-33.
26. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:536-45.
27. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
28. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40:168-72.
29. Bottiglieri T, Crellin R, Reynolds EH. Folate and neuropsychiatry. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker, 1995:435-62.